Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate

Drug Metabolism and Disposition

Volumn 31, Issue 5, 2003, Pages 572-579

  Lu, Hong ^a   Meng, Xiaofeng ^a   Yang, Chung S ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' O METHYL EPIGALLOCATECHIN; 4' O METHYL EPIGALLOCATECHIN GALLATE; 4',4'' DI O METHYL EPIGALLOCATECHIN GALLATE; CATECHOL METHYLTRANSFERASE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; ENZYMOLOGY; FEMALE; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; LIVER; LIVER CYTOSOL; MALE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE;

ANIMALS; CATECHIN; CATECHOL O-METHYLTRANSFERASE; CYTOSOL; ENZYME INHIBITORS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCURONIDES; INTESTINES; LIVER; MALE; METHYLATION; MICE; MICROSOMES, LIVER; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; SWINE; TEA;

ANIMALIA;

EID: 0037403751     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.5.572     Document Type: Conference Paper

References (27)

1. Bertoldi M. Gonsalvi M, and Voltattomi CB (2001) Green tea polyphenols: novel irreversible inhibitors of dopa decarboxylase. Biochem Biophys Res Commun 284:90-93.
2. Chan DK, Woo J, Ho SC, Pang CP, Law LK, Ng PW, Hung WT, Kwok T, Hui E, Orr K, et al. (1998) Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 65:781-784.
3. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Longstreth WT Jr, and Swanson PD (2002) Parkinson's disease risks associated with cigarette smoking, alcohol consumption and caffeine intake. Am J Epidemiol 155:732-738.
4. Chen L, Lee MJ, Li H, and Yang CS (1997) Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 25:1045-1050.
5. Cheng X (1995) Structure and function of DNA methyltransferases. Annu Rev Biophys Biomol Struct 24:293-318.
6. Dulloo AG, Seydoux J, Girardier L, Chantre P, and Vandermander J (2000) Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 24:252-258.
7. Gugler R and Dengler HJ (1973) Inhibition of human liver catechol-O-methyltransferase by flavonoids. Naunyn-Schmiedeberg's Arch Pharmacol 276:223-233.
8. Hong JY, Pan JM, Ning SM, and Yang CS (1989) Molecular basis for the sex-related difference in renal N-nitrosodimethylamine demethylase in C3H/HeJ mice. Cancer Res 49:2973-2979.
9. Keranen T, Gordin A, Karlsson M, Korpela K, Pentikainen PJ, Rita H, Schultz E, Seppala L, and Wikberg T (1994) Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone. Eur J Clin Pharmacol 46:151-157.
10. Kida K, Suzuki M, Matsumoto N. Nanjo F, and Hara Y (2000) Identification of biliary metabolites of (-)-epigallocatechin gallate in rats. J Agric Food Chem 48:4151-4155.
11. Kohri T, Nanjo F, Suzuki M, Seto R, Matsumoto N, Yamakawa M, Hojo H, Hara Y, Desai D, Amin S, et al. (2001) Synthesis of (-)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration. J Agric Food Chem 49:1042-1048.
12. Lautala P, Ulmanen I, and Taskinen J (1999) Radiochemical high-performance liquid chromatographic assay for the determination of catechol O-methyltransferase activity towards various substrates. J Chromatogr B Biomed Sci Appl 736:143-151.
13. Lautala P, Ulmanen I, and Taskinen J (2001) Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. Mol Pharmacol 59:393-402.
14. Levites Y, Youdim MB, Maor G, and Mandel S (2002) Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63:21-29.
15. Li C, Meng X, Winnik B, Lee MJ, Lu H, Sheng S, Buckley B, and Yang CS (2001) Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem Res Toxicol 14:702-707.
16. Lu H. Meng X, Li C, Sang S, Patten C, Sheng S, Hong J, Bai N, Winnik B. Ho CT, and Yang CS (2003) Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 31:452-461.
17. Mannisto PT and Kaakkola S (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology and clinical efficacy of the new selective COMT inhibitors, Pharmacol Rev 51:593-628.
18. Meng X, Lee MJ, Li C, Sheng S, Zhu N, Sang S, Ho CT, and Yang CS (2001) Formation and identification of 4′-O-methyl-(-)-epigallocatechin in humans. Drug Metab Dispos 29:789-793.
19. Meng X, Sang S, Zhu N, Lu H, Sheng S, Lee MJ, Ho CT, and Yang CS (2002) Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice and rats. Chem Res Toxicol 15:1042-1050.
20. Nissinen E, Linden IB, Schultz E, and Pohto P (1992) Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone. Naunyn-Schmiedeberg's Arch Pharmacol 346:262-266.
21. Okushio K, Suzuki M, Matsumoto N, Nanjo F, and Hara Y (1999) Methylation of tea catechins by rat liver homogenates. Biosci Biotechnol Biochem 63:430-432.
22. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, and Fujiki H (1998) Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19:1771-1776.
23. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, and Schantz SP (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer-Epidemiol Biomarkers Prev 7:351-354.
24. Yang CS and Landau JM (2000) Effects of tea consumption on nutrition and health. J Nutr 130:2409-2412.
25. Yang CS, Maliakal P. and Meng X (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25-54.
26. Zhu BT, Patel UK, Cai MX, and Conney AH (2000) O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab Dispos 28:1024-1030.
27. Zhu BT, Patel UK, Cai MX, Lee AJ, and Conney AH (2001) Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-O-methyltransferase. Xenobiotica 31:879-890.